Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Transform your travel with credit card points for Airbnb stays. Discover how to save more on your accommodations.
18,738 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Bruno Mars is back with a new solo project, and the tracklist drop isn’t just music news—it’s a case study in modern ...
Struggling to manage money without breaking the bank? Affordable financial planning software options exist that can a...
As Veracyte approaches its Q4 2025 earnings, investors want a clear view of revenue momentum, margins, and reimbursem...
A clear, investor-friendly look at arcosa (aca) 2025 earnings through the lens of the Q4 2025 earnings call. Learn wh...
Starting with $1,000 doesn't mean you have to settle for small gains. This guide lays out a clear framework to find t...
A disciplined, evidence-based investor can spot a rare setup: rapid revenue growth, improving unit economics, and a c...
As markets swing in early 2026, many investors pay active fees for funds that closely track benchmarks. Here’s a fast...
A billionaire activist investor is stepping in with a bold move on Pinterest. This deep dive breaks down what this co...
Uber stock has slipped about 12% in three months, trading near $74 after a strong run. This article breaks down what’...
Oil is rising and energy stocks are drawing cautious buyers. This guide shows two resilient oil producers you could b...
A notable AI stock has fallen about 30% this year. This article lays out a practical, battle-tested framework to judg...